BRCA2 and cancer: However, BRCA1 and BRCA2 mutant cells or cancers have substantially different structural rearrangement spectra, whereas their SBS phenotypes are indistinguishable5,8, which suggests that increased SBS mutagenesis has an important role in the similar tumorigenic consequences of BRCA1 or BRCA2 gene defects.